Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

5.9%

1 terminated/withdrawn out of 17 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

41%

7 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
6(37.5%)
Phase 4
4(25.0%)
N/A
3(18.8%)
Phase 3
3(18.8%)
16Total
Phase 2(6)
Phase 4(4)
N/A(3)
Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT04921189Phase 2Completed

Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors

Role: collaborator

NCT05964179Not ApplicableCompleted

Effects of Daily Eating Duration on Health

Role: lead

NCT03838406Not ApplicableCompleted

BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer

Role: lead

NCT02550665Phase 3Completed

Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg

Role: collaborator

NCT02484352Phase 4Completed

Optimal Dose of Intravenous Oxycodone for Endotracheal Intubation

Role: collaborator

NCT01974024Phase 3Completed

Dexamethasone-induced Hiccup in Chemotherapy Patients Treated by Methylprednisolone Rotation

Role: lead

NCT02932995Unknown

DXR Stent for Vascular Healing and Thrombus Formation: OCT Study

Role: lead

NCT02802644Phase 4Unknown

The Effect of DPP4 Inhibitor on Vasclular Healing

Role: lead

NCT01068392Phase 2Completed

Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)

Role: collaborator

NCT01730677Phase 2Unknown

Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab

Role: collaborator

NCT01127555Phase 2Completed

Salvage mFOLFOX in BTC After Failure of Gemcitabine

Role: lead

NCT01501669Phase 3Unknown

Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer

Role: collaborator

NCT01096745Phase 2Terminated

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer

Role: collaborator

NCT01170104Phase 2Unknown

Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)

Role: lead

NCT01365572Phase 4Unknown

New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )

Role: collaborator

NCT00823550Phase 4Unknown

Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients

Role: collaborator

NCT00654342Not ApplicableUnknown

Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer

Role: lead

All 17 trials loaded